Zeeshan Ahmed Khattak: Why Every Pharmacist Should Consider an Anticoagulation Certification
Zeeshan Ahmed Khattak, Pharmacist (IP/Oncology) at Abu Dhabi Stem Cells Center, shared on LinkedIn:
”Why Every Pharmacist Should Consider an Anticoagulation Certification
Anticoagulants are among the highest-risk medications in clinical practice.
Specialized Anticoagulation Certification empowers pharmacists to play a critical role in ensuring safe, effective, and evidence-based therapy.
Key Benefits for Pharmacists
- Enhanced knowledge of warfarin, DOACs, and parenteral anticoagulants
- Improved skills in dose adjustment, monitoring, and bleeding risk management
- Stronger collaboration with physicians in anticoagulation clinics
- Reduced medication errors and improved patient outcomes
- Career advancement in clinical pharmacy, cardiology, hematology, and ambulatory care
Trusted References and Evidence-Based Sources
• ACCP Antithrombotic Therapy Guidelines
• American Heart Association (AHA)
• American College of Cardiology (ACC)
• CHEST Guidelines on Antithrombotic Therapy
• ISTH (International Society on Thrombosis and Haemostasis)
Recognized Anticoagulation Certifications
• Certified Anticoagulation Care Provider (CACP) – National Certification Board for Anticoagulation Providers
• Anticoagulation Therapy Certificate Program – ACCP
• ASHP Anticoagulation Management Resources
In today’s evolving healthcare landscape, pharmacist-led anticoagulation management is no longer optional—it’s essential.
Investing in anticoagulation certification means safer patients, stronger clinical impact, and professional growth.”
Stay updated with Hemostasis Today.
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination
-
Jun 1, 2026, 18:49James P. Crowley: How Combining Vitamin D analogs with Chemotherapy Impacts Survival Outcomes
-
Jun 1, 2026, 18:42Debojyoti Chakraborty: Small But Meaningful Steps Toward A Gene Editing Trial For Sickle Cell Disease In India
-
Jun 1, 2026, 17:14Tiffany Gacel: What an Incredible Day With NBCA and The Red Bus Tour at Memorial at Gulfport?
-
Jun 1, 2026, 17:12Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab
-
Jun 1, 2026, 17:00Azusa Nagao: Organizing the Symposium on Women and Bleeding Disorders at JSTH Annual Meeting
-
Jun 1, 2026, 16:57Kuljeet Kaur: Approach to Anemia – More Than Just a Low Hemoglobin